Vitiligo after combination therapy of pegylated interferon-α-2a, ribavirin and vitamin D in a patient with chronic hepatitis C


  • Conflict of interest: None.

Correspondence: Naoki Oiso, M.D., Ph.D., Department of Dermatology, Kinki University Faculty of Medicine, 377-2 Ohno-Higashi, Osaka-Sayama, Osaka 589-8511, Japan. Email:

No abstract is available for this article.